Cooperation between "Purelab" and"Baynouna Genetic Solutions" To promote diagnostic innovation and biotechnology in the UAE

Abu Dhabi, May 25 / WAM / Purelab, a subsidiary of PureHealth Group, signed a memorandum of understanding with Baynouna Genetic Solutions, with the aim of enhancing cooperation in the fields of diagnostic innovation, synthetic biology, and molecular sciences, in addition to supporting research and development initiatives in the UAE.
The memorandum embodies a joint strategic direction to consolidate the UAE’s position as an advanced regional center for health innovation and biotechnology, through developing local scientific capabilities and supporting the knowledge and innovation-based economy system, in line with the country’s national priorities in the health care sector.
Under the memorandum, the two sides will work to launch joint research initiatives, implement competency verification studies, and develop pilot projects, in addition to preparing specialized programs to qualify human competencies in the fields of advanced diagnosis and biotechnology, in a way that strengthens the system of scientific research and health innovation in the country.
The collaboration extends to exploring next-generation molecular diagnostic solutions and synthetic biology applications designed to meet the accelerating requirements of the healthcare sector in the UAE, and keep pace with future transformations in medical sciences and advanced biotechnology.
This cooperation comes within the framework of supporting the comprehensive vision of the UAE aimed at promoting innovation in the health care, biotechnology and scientific research sectors, in conjunction with supporting the growth of the life sciences system and consolidating the foundations of the knowledge economy in the country.
Arindam Haldar, CEO of Purelab, said that the strategic cooperation with Baynouna Genetic Solutions comes from a shared vision to enhance innovation in health care and scientific capabilities in the UAE, noting that the partnership aims to advance local innovation in the field of diagnosis, and support research and development efforts, which contributes to providing advanced health care solutions that keep pace with the requirements of the future.
For his part, Dr. Omar Najm, CEO of Baynouna Genetic Solutions, stressed that this cooperation represents a qualitative step to support the national innovation process in the fields of biotechnology and molecular sciences, pointing out that employing joint expertise between the two sides would accelerate the pace of scientific progress, enhance local capabilities, and support the development of next-generation health care solutions, in line with the national priorities of the UAE.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Twitter


